Emerging treatments in multiple sclerosis
Détails
ID Serval
serval:BIB_BDCF0293C1CD
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Emerging treatments in multiple sclerosis
Périodique
European Neurology
ISSN
0014-3022 (Print)
Statut éditorial
Publié
Date de publication
1997
Volume
38
Numéro
3
Pages
216-21
Notes
Journal Article
Review
Review
Résumé
Currently used and developing therapies for multiple sclerosis (MS) are dealing with the treatment of acute exacerbations, the prevention of relapses and of the progression of neurological handicap, the treatment of symptoms, and the repair of demyelinated lesions. New insights into the treatment of acute relapses as well as recent immunomodulatory and immunosuppressive agents tested in MS are exposed in this brief review. Interferon-beta (1a and 1b), copolymer 1 and new immunosuppressive therapies are particularly discussed with emphasis on their potential to alter the course of MS.
Mots-clé
Adjuvants, Immunologic/therapeutic use
Disease Progression
Humans
Immunosuppressive Agents/therapeutic use
Interferon-beta/therapeutic use
Multiple Sclerosis/*therapy
Palliative Care/trends
Recurrence/prevention & control
Steroids/therapeutic use
Pubmed
Web of science
Création de la notice
25/01/2008 13:46
Dernière modification de la notice
20/08/2019 16:32